GovWire

Phase 2

Administrative timetable

Date of referral: 31 March 2023

Statutory deadline: 5 October 2023

• Administrative timetable (PDF, 91.9 KB) (17.5.23)

Contact

UnitedHealth.EMIS@cma.gov.uk

Final report

29 September 2023: The CMA has published its final report.

• Summary of final report (PDF, 140KB) (29.9.23)
• Press release: CMA clears NHS healthcare tech deal (29.9.23)

Responses to provisional findings

• UH/EMIS (PDF, 139KB) (13.9.23)
• Market Participant A (PDF, 65KB) (13.9.23)
• FDB (PDF, 219KB) (13.9.23)
• TPP (PDF, 106KB) (13.9.23)

Provisional findings

11 August 2023: The CMA has provisionally cleared the anticipated acquisition by UnitedHealth Group Incorporated of EMIS Group Plc.

The deadline for submitting responses to the provisional findings is 5pm on Friday 1 September 2023.

• Provisional findings (PDF, 1,112KB) (11.8.23)
• Appendices and glossary (PDF, 259KB) (11.8.23)
• Summary of provisional findings (PDF, 139KB) (11.8.23)
• Notice of provisional findings (PDF, 122KB) (11.8.23)
• Press release: CMA provisionally clears NHS healthcare tech deal (11.8.23)

Response to the issues statement

• UnitedHealth Group Incorporated and EMIS Group PLC (PDF, 636KB) (22.6.23)
• Investment firm (PDF, 268KB) (22.6.23)

Issues statement

17 May 2023: The issues statement sets out the scope of the inquiry. It outlines initial theories on what might be adversely affecting competition, but it does not set out findings or conclusions.

• Issues statement (PDF, 215 KB) (17.5.23)

Notice of extension

• Notice of extension of inquiry period (PDF, 96.3KB) (27.4.23)

Inquiry group appointed

31 March 2023: The CMA has appointed the inquiry group.Kirstin Baker (Chair), Ulrike Hotopp, Frances McLeman and Sir Kenneth Parker.

Terms of reference

31 March 2023: The CMA has referred the anticipated acquisition by UnitedHealth Group Incorporated of EMIS Group Plc for an in-depth investigation.

• Terms of reference (PDF, 99.8 KB) (31.3.23)

Phase 1

Statutory timetable

Reference decision

31 March 2023: The CMA has referred the anticipated acquisition by UnitedHealth Group Incorporated of EMIS Group Plc for an in-depth investigation, on the basis that, on the information currently available to it, it is or may be the case that this merger has resulted or may be expected to result in a substantial lessening of competition within a market or markets in the United Kingdom.

• Decision to refer (PDF, 161 KB) (17.5.23)

Reference unless undertakings accepted

17 March 2023: The CMA has decided, on the information currently available to it, that it is or may be the case that this merger may be expected to result in a substantial lessening of competition within a market or markets in the United Kingdom. This merger will be referred for a phase 2 investigation unless the parties offer acceptable undertakings to address these competition concerns.

• Full text decision (PDF, 703 KB) (17.5.23)
• Summary of Phase 1 decision (PDF. 158KB) (17.3.23)
• Press release: Healthcare deal could lead to higher costs for NHS (17.3.23)

Launch of merger inquiry

20 January 2023: The CMA announced the launch of its merger inquiry by notice to the parties.

• Commencement notice (PDF, 102KB) (20.1.23)

Invitation to comment: closed

20 January 2023: The Competition and Markets Authority (CMA) is considering whether it is or may be the case that this transaction, if carried into effect, will result in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2022 and, if so, whether th

View the original news story